Veeva Systems Inc. (0LO3.L)
USD 235.69
(0.97%)
USD 235.69
(0.97%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -647.71 Million USD | 21.54% |
| 2023 | -825.48 Million USD | 23.81% |
| 2022 | -1.08 Billion USD | -62.34% |
| 2021 | -667.38 Million USD | -58.18% |
| 2020 | -421.9 Million USD | 23.43% |
| 2019 | -550.97 Million USD | -72.08% |
| 2018 | -320.18 Million USD | -47.14% |
| 2017 | -217.6 Million USD | -64.63% |
| 2016 | -132.17 Million USD | -2.26% |
| 2015 | -129.25 Million USD | 50.76% |
| 2014 | -262.5 Million USD | -723.16% |
| 2013 | -31.89 Million USD | -88.92% |
| 2012 | -16.88 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | -647.71 Million USD | 5.59% |
| 2024 Q3 | -686.04 Million USD | -0.28% |
| 2024 Q1 | -1.03 Billion USD | -25.43% |
| 2024 FY | -647.71 Million USD | 21.54% |
| 2024 Q2 | -684.1 Million USD | 33.93% |
| 2023 Q2 | -1.07 Billion USD | 9.2% |
| 2023 Q3 | -803.26 Million USD | 25.4% |
| 2023 FY | -825.48 Million USD | 23.81% |
| 2023 Q1 | -1.18 Billion USD | -9.46% |
| 2023 Q4 | -825.48 Million USD | -2.77% |
| 2022 Q2 | -1 Billion USD | 10.58% |
| 2022 Q1 | -1.12 Billion USD | -68.57% |
| 2022 FY | -1.08 Billion USD | -62.34% |
| 2022 Q4 | -1.08 Billion USD | 0.96% |
| 2022 Q3 | -1.09 Billion USD | -8.74% |
| 2021 Q1 | -668.21 Million USD | -58.38% |
| 2021 FY | -667.38 Million USD | -58.18% |
| 2021 Q4 | -667.38 Million USD | -16.02% |
| 2021 Q2 | -738.47 Million USD | -10.51% |
| 2021 Q3 | -575.25 Million USD | 22.1% |
| 2020 Q4 | -421.9 Million USD | 51.24% |
| 2020 Q1 | -728.88 Million USD | -32.29% |
| 2020 FY | -421.9 Million USD | 23.43% |
| 2020 Q2 | -805.22 Million USD | -10.47% |
| 2020 Q3 | -865.26 Million USD | -7.46% |
| 2019 Q3 | -467.64 Million USD | 8.62% |
| 2019 FY | -550.97 Million USD | -72.08% |
| 2019 Q4 | -550.97 Million USD | -17.82% |
| 2019 Q2 | -511.73 Million USD | -11.19% |
| 2019 Q1 | -460.23 Million USD | -43.74% |
| 2018 Q2 | -409.22 Million USD | -11.91% |
| 2018 Q4 | -320.18 Million USD | -3.02% |
| 2018 Q1 | -365.66 Million USD | -68.04% |
| 2018 FY | -320.18 Million USD | -47.14% |
| 2018 Q3 | -310.79 Million USD | 24.05% |
| 2017 Q2 | -210.36 Million USD | 14.47% |
| 2017 Q4 | -217.6 Million USD | -5.59% |
| 2017 FY | -217.6 Million USD | -64.63% |
| 2017 Q1 | -245.94 Million USD | -86.07% |
| 2017 Q3 | -206.07 Million USD | 2.04% |
| 2016 FY | -132.17 Million USD | -2.26% |
| 2016 Q2 | -119.77 Million USD | -11.36% |
| 2016 Q4 | -132.17 Million USD | -21.72% |
| 2016 Q3 | -108.59 Million USD | 9.34% |
| 2016 Q1 | -107.56 Million USD | 16.78% |
| 2015 FY | -129.25 Million USD | 50.76% |
| 2015 Q4 | -129.25 Million USD | 2.18% |
| 2015 Q3 | -132.13 Million USD | 5.7% |
| 2015 Q2 | -140.11 Million USD | 25.82% |
| 2015 Q1 | -188.88 Million USD | 28.04% |
| 2014 FY | -262.5 Million USD | -723.16% |
| 2014 Q4 | -262.5 Million USD | -2.09% |
| 2014 Q3 | -257.14 Million USD | -566.03% |
| 2014 Q2 | -38.6 Million USD | 12.95% |
| 2014 Q1 | -44.35 Million USD | -39.08% |
| 2013 Q4 | -31.89 Million USD | 0.0% |
| 2013 FY | -31.89 Million USD | -88.92% |
| 2012 FY | -16.88 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | -757.476% |
| Accuray Incorporated | 103.58 Million USD | 725.289% |
| Align Technology, Inc. | -840.47 Million USD | 22.935% |
| Elevance Health Inc. | 18.59 Billion USD | 103.483% |
| AxoGen, Inc. | 32.26 Million USD | 2107.413% |
| Boston Scientific Corporation | 8.23 Billion USD | 107.868% |
| CVS Health Corporation | 71.18 Billion USD | 100.91% |
| Cardinal Health, Inc. | 476 Million USD | 236.074% |
| Centene Corporation | 506 Million USD | 228.006% |
| DaVita Inc. | 10.65 Billion USD | 106.081% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 101.583% |
| Hologic, Inc. | 374.4 Million USD | 273.0% |
| Humana Inc. | 5.51 Billion USD | 111.736% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | 231.13% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | 111.956% |
| Masimo Corporation | 804 Million USD | 180.561% |
| McKesson Corporation | 889 Million USD | 172.858% |
| Patterson Companies, Inc. | 648.47 Million USD | 199.882% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | 113.831% |
| ResMed Inc. | 635.57 Million USD | 201.91% |
| Henry Schein, Inc. | 2.57 Billion USD | 125.203% |
| Teladoc Health, Inc. | 468.6 Million USD | 238.222% |
| Universal Health Services, Inc. | 5.24 Billion USD | 112.344% |
| Baxter International Inc. | 11.16 Billion USD | 105.801% |
| Becton, Dickinson and Company | 14.46 Billion USD | 104.478% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 75.653% |
| Danaher Corporation | 13.49 Billion USD | 104.801% |
| Stryker Corporation | 10.02 Billion USD | 106.462% |
| Medtronic plc | 23.67 Billion USD | 102.735% |